-
Mashup Score: 1ESH - European School of Haematology - 10 month(s) ago
7th Translational Research ConferenceLymphoid MalignanciesOctober 20-22, 2023 – Estoril, Portugal #ESHLYMPHOID2023 Chairs: Michael Hallek, Georg Lenz, Laurie Sehn, Louis Staudt REGISTRATION & ABSTRACT SUBMISSION ARE OPEN! ABOUT THE CONFERENCE: ESH Translational Research Conferences focus on leading-edge basic, clinical and therapeutic research and future perspectives.The presentation of…
Categories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 2Please wait whilst we redirect you - 1 year(s) ago
About ScienceDirectRemote accessShopping cartAdvertiseContact and supportTerms and conditionsPrivacy policyWe use cookies to help provide and enhance our service and tailor content and ads. By continuing you agree to the use of cookies.Copyright © 2023 Elsevier B.V. or its licensors or contributors. ScienceDirect® is a registered trademark of Elsevier B.V.ScienceDirect® is a registered trademark…
Source: www.sciencedirect.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 4Burkitt’s Lymphoma | NEJM - 2 year(s) ago
Review Article from The New England Journal of Medicine — Burkitt’s Lymphoma
Source: New England Journal of MedicineCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Hemato - 2 year(s) ago
Hemato, an international, peer-reviewed Open Access journal.
Source: www.mdpi.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 4Aberrant expansion of spontaneous splenic germinal centers induced by hallmark genetic lesions of aggressive lymphoma - 2 year(s) ago
Key Points. MCD-associated genetic lesions strongly promoted accumulation of B cells in splenic germinal centers (GCs) of unimmunized miceMice engineered to har
Source: American Society of HematologyCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 2Virtual Lymphoma Rounds: Washington, DC – March 22, 2022 - 2 year(s) ago
Time: 7:00 PM – 8:30 PM ET
Source: Lymphoma Research FoundationCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 11Enhanced detection of minimal residual disease by targeted sequencing of phased variants in circulating tumor DNA - Nature Biotechnology - 3 year(s) ago
The sensitivity of circulating tumor DNA detection is improved by identifying sequences with two or more mutations.
Source: Nature BiotechnologyCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Source: gotoper.6connex.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 2Lymphoid Malignancies Branch - 4 year(s) ago
We combine basic research, preclinical investigation, and drug development with innovative, therapeutic clinical trials to treat lymphoid malignancies.
Source: Center for Cancer ResearchCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Reply to M. Hertzberg et al - 4 year(s) ago
Hertzberg et al1 commented on our report of etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab (DA-EPOCH-R) in Burkitt lymphoma (BL).2 The diagnosis of BL is relatively straight forward because of its readily identifiable histology and immunophenotype and the MYC translocation, which is optional in the WHO diagnostic criteria.3 Among 65 centrally reviewed pathology…
Source: Journal of Clinical OncologyCategories: Hem/Oncs, Latest HeadlinesTweet
RT @ESHaematology: #ESHLYMPHOID2023 ONLY 2 WEEKS LEFT TO SUBMIT YOUR ABSTRACT! Proceed now ➡ https://t.co/H7msA3tCdI 🗓️ Oct. 20-22, 2023 in…